GRST Stock Overview
Operates behavioral healthcare space specifically in the treatment of substance use disorders. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Ethema Health Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0005 |
| 52 Week High | US$0.001 |
| 52 Week Low | US$0.0002 |
| Beta | 2.56 |
| 11 Month Change | -28.57% |
| 3 Month Change | -37.50% |
| 1 Year Change | -16.67% |
| 33 Year Change | -54.55% |
| 5 Year Change | -98.00% |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| GRST | US Healthcare | US Market | |
|---|---|---|---|
| 7D | -28.6% | -1.2% | -1.0% |
| 1Y | -16.7% | 2.5% | 30.3% |
Return vs Industry: GRST underperformed the US Healthcare industry which returned 1.1% over the past year.
Return vs Market: GRST underperformed the US Market which returned 30.4% over the past year.
Price Volatility
| GRST volatility | |
|---|---|
| GRST Average Weekly Movement | 17.1% |
| Healthcare Industry Average Movement | 7.0% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.7% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: GRST's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: GRST's weekly volatility has decreased from 32% to 17% over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 65 | Shawn Leon | ethemahealth.com |
Ethema Health Corporation operates behavioral healthcare space specifically in the treatment of substance use disorders. It offers rehabilitation services. The company was formerly known as GreeneStone Healthcare Corporation and changed its name to Ethema Health Corporation in April 2017.
Ethema Health Corporation Fundamentals Summary
| GRST fundamental statistics | |
|---|---|
| Market cap | US$5.02m |
| Earnings (TTM) | -US$2.13m |
| Revenue (TTM) | US$5.68m |
0.7x
P/S Ratio-1.8x
P/E RatioIs GRST overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| GRST income statement (TTM) | |
|---|---|
| Revenue | US$5.68m |
| Cost of Revenue | US$3.06m |
| Gross Profit | US$2.61m |
| Other Expenses | US$4.75m |
| Earnings | -US$2.13m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.00028 |
| Gross Margin | 46.03% |
| Net Profit Margin | -37.59% |
| Debt/Equity Ratio | -96.2% |
How did GRST perform over the long term?
See historical performance and comparison